Verona Pharma plc (VRNA) Ownership

$106.79

south_east
-$0.03 (-0.03%)
Day's range
$106.79
Day's range
$106.85

Verona Pharma plc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
PENTWATER CAPITAL MANAGEMENT LP 11/14/2025 5.30 M $565.56 M   100.00% 6.19%
HBK INVESTMENTS L P 11/14/2025 4.26 M $454.97 M   100.00% 4.98%
BLACKROCK, INC. 11/12/2025 3.83 M $408.35 M   1,013.40% 4.47%
FIL LTD 11/13/2025 3.49 M $372.26 M   100.00% 4.07%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 11/14/2025 3.38 M $361.10 M   0.00% 3.95%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 11/14/2025 3.27 M $349.11 M   100.00% 3.82%
GLAZER CAPITAL, LLC 11/13/2025 3.21 M $342.10 M   100.00% 3.74%
NEA MANAGEMENT COMPANY, LLC 11/14/2025 2.25 M $240.42 M   -0.45% 2.63%
GOLDMAN SACHS GROUP INC 11/14/2025 1.94 M $206.51 M   -26.06% 2.26%
BALYASNY ASSET MANAGEMENT L.P. 11/14/2025 1.86 M $198.85 M   213.89% 2.18%
MILLENNIUM MANAGEMENT LLC 11/14/2025 1.80 M $191.73 M   376.38% 2.10%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 11/14/2025 1.79 M $190.52 M   -16.74% 2.08%
MORGAN STANLEY 11/14/2025 1.58 M $168.16 M   764.31% 1.84%
WHITEBOX ADVISORS LLC 11/14/2025 1.57 M $167.16 M   100.00% 1.83%
JPMORGAN CHASE & CO 11/26/2025 1.41 M $150.97 M   296.73% 1.65%
BARCLAYS PLC 11/12/2025 1.39 M $148.72 M   1,160.02% 1.63%
VIVO CAPITAL, LLC 11/14/2025 1.39 M $148.69 M   0.00% 1.63%
SYQUANT CAPITAL SAS 10/28/2025 1.21 M $128.94 M   100.00% 1.41%
ALPINE ASSOCIATES MANAGEMENT INC. 11/06/2025 1.16 M $123.47 M   100.00% 1.35%
UBS OCONNOR LLC 11/14/2025 1.11 M $118.05 M   100.00% 1.29%
JANUS HENDERSON GROUP PLC 11/14/2025 1.01 M $107.84 M   -83.53% 1.18%
DUQUESNE FAMILY OFFICE LLC 11/14/2025 1.00 M $106.93 M   0.00% 1.17%
POLAR ASSET MANAGEMENT PARTNERS INC. 12/01/2025 970.00 K $103.51 M   8,262.07% 1.13%
KRYGER CAPITAL LTD 11/14/2025 962.34 K $102.69 M   100.00% 1.12%
FIRST TRUST CAPITAL MANAGEMENT L.P. 11/17/2025 909.12 K $97.01 M   100.00% 1.06%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 811.84 K $86.63 M   153.92% 0.95%
BANK OF AMERICA CORP /DE/ 11/14/2025 721.21 K $76.96 M   59.11% 0.84%
ALLIANCEBERNSTEIN L.P. 11/14/2025 718.34 K $76.65 M   490.79% 0.84%
EVENTIDE ASSET MANAGEMENT, LLC 11/14/2025 680.93 K $72.66 M   -74.92% 0.80%
TIG ADVISORS, LLC 11/14/2025 635.27 K $67.79 M   100.00% 0.74%
MAGNETAR FINANCIAL LLC 11/13/2025 628.26 K $67.04 M   100.00% 0.73%
AFFINITY ASSET ADVISORS, LLC 11/13/2025 625.00 K $66.69 M   2.46% 0.73%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 615.90 K $65.72 M   317.84% 0.72%
AISLING CAPITAL MANAGEMENT LP 11/12/2025 615.35 K $65.66 M   0.00% 0.72%
NEXPOINT ASSET MANAGEMENT, L.P. 11/14/2025 584.60 K $62.38 M   100.00% 0.68%
PERCEPTIVE ADVISORS LLC 11/14/2025 524.09 K $55.93 M   -90.48% 0.61%
VERITION FUND MANAGEMENT LLC 11/14/2025 517.01 K $55.17 M   3,863.90% 0.60%
AQR ARBITRAGE LLC 11/14/2025 513.78 K $54.83 M   100.00% 0.60%
TWIN SECURITIES, INC. 11/14/2025 501.11 K $53.47 M   100.00% 0.59%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 11/10/2025 500.00 K $53.36 M   100.00% 0.58%
WESTCHESTER CAPITAL MANAGEMENT, LLC 11/14/2025 483.66 K $51.61 M   100.00% 0.56%
ODDO BHF ASSET MANAGEMENT SAS 11/14/2025 467.47 K $49.88 M   90.53% 0.55%
CITADEL ADVISORS LLC 11/14/2025 461.87 K $49.29 M   -66.93% 0.54%
HUDSON BAY CAPITAL MANAGEMENT LP 11/13/2025 455.33 K $48.59 M   100.00% 0.53%
SCHONFELD STRATEGIC ADVISORS LLC 11/14/2025 438.06 K $46.75 M   919.93% 0.51%
MAN GROUP PLC 11/14/2025 415.73 K $44.36 M   100.00% 0.49%
ABSOLUTE GESTAO DE INVESTIMENTOS LTDA. 11/13/2025 413.43 K $44.12 M   100.00% 0.48%
TUDOR INVESTMENT CORP ET AL 12/09/2025 400.00 K $42.68 M   100.00% 0.47%
ARTIA GLOBAL PARTNERS LP 11/14/2025 379.00 K $40.44 M   -58.99% 0.44%
CAPSTONE INVESTMENT ADVISORS, LLC 11/14/2025 375.00 K $40.02 M   100.00% 0.44%

Verona Pharma plc institutional Ownership - FAQ's

During the previous two years, 399 institutional investors and hedge funds held shares of Verona Pharma plc. The most heavily invested institutionals were:

Pentwater Capital Management LP: 5.3 M

HBK INVESTMENTS L P: 4.26 M

BlackRock, Inc.: 3.83 M

FIL Ltd: 3.49 M

Frazier Life Sciences Management, L.P.: 3.38 M

DAVIDSON KEMPNER CAPITAL MANAGEMENT LP: 3.27 M

90.03% of Verona Pharma plc stock is owned by institutional investors.

Institutional investors have bought a total of 83.52 M shares in the last 24 months. This purchase volume represents approximately $8.92 B in transactions.